serw-MX  [xml]  

 DeCS Categories

C04 Neoplasms .
C04.588 Neoplasms by Site .
C04.588.322 Endocrine Gland Neoplasms .
C04.588.322.455 Ovarian Neoplasms .
C13 Female Urogenital Diseases and Pregnancy Complications .
C13.351 Female Urogenital Diseases .
C13.351.500 Genital Diseases, Female .
C13.351.500.056 Adnexal Diseases .
C13.351.500.056.630 Ovarian Diseases .
C13.351.500.056.630.705 Ovarian Neoplasms .
C13.351.937 Urogenital Neoplasms .
C13.351.937.418 Genital Neoplasms, Female .
C13.351.937.418.685 Ovarian Neoplasms .
C17 Skin and Connective Tissue Diseases .
C17.800 Skin Diseases .
C17.800.600 Photosensitivity Disorders .
C17.800.600.725 Sunburn .
C19 Endocrine System Diseases .
C19.344 Endocrine Gland Neoplasms .
C19.344.410 Ovarian Neoplasms .
C19.391 Gonadal Disorders .
C19.391.630 Ovarian Diseases .
C19.391.630.705 Ovarian Neoplasms .
C26 Wounds and Injuries .
C26.200 Burns .
C26.200.855 Sunburn .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.519 Molecular Mechanisms of Pharmacological Action .
D27.505.519.124 Alkylating Agents .
D27.505.954 Therapeutic Uses .
D27.505.954.122 Anti-Infective Agents .
D27.505.954.122.388 Antiviral Agents .
D27.505.954.122.388.077 Anti-Retroviral Agents .
D27.505.954.122.388.077.088 Anti-HIV Agents .
D27.505.954.444 Dermatologic Agents .
D27.505.954.444.600 Photosensitizing Agents .
D27.505.954.600 Radiation-Sensitizing Agents .
D27.505.954.600.710 Photosensitizing Agents .
D27.505.954.796 Respiratory System Agents .
D27.505.954.796.050 Anti-Asthmatic Agents .
D27.720 Specialty Uses of Chemicals .
D27.720.470 Laboratory Chemicals .
D27.720.470.410 Indicators and Reagents .
D27.720.470.410.080 Affinity Labels .
D27.720.470.410.080.600 Photoaffinity Labels .
D27.888 Toxic Actions .
D27.888.569 Noxae .
D27.888.569.035 Alkylating Agents .
E02 Therapeutics .
E02.319 Drug Therapy .
E02.319.267 Drug Administration Routes .
E02.319.267.120 Administration, Topical .
E05 Investigative Techniques .
E05.318 Epidemiologic Methods .
E05.318.740 Statistics as Topic .
E05.318.740.250 Cluster Analysis .
E05.318.740.250.675 Small-Area Analysis .
N05 Health Care Quality, Access, and Evaluation .
N05.715 Quality of Health Care .
N05.715.360 Health Care Evaluation Mechanisms .
N05.715.360.750 Statistics as Topic .
N05.715.360.750.200 Cluster Analysis .
N05.715.360.750.200.750 Small-Area Analysis .
N06 Environment and Public Health .
N06.850 Public Health .
N06.850.520 Epidemiologic Methods .
N06.850.520.830 Statistics as Topic .
N06.850.520.830.250 Cluster Analysis .
N06.850.520.830.250.675 Small-Area Analysis .
 Synonyms & Historicals
Photosensitizing Agents .
Photosensitizing Effect .
Photosensitizing Effects .
Agents, Photosensitizing .
Effect, Photosensitizing .
Effects, Photosensitizing .
Photosensitizers .
Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. .
Drug Administration Routes .
Administration Routes, Drug .
Administration Route, Drug .
Drug Administration Route .
Route, Drug Administration .
Routes, Drug Administration .
The various ways of administering a drug or other chemical to a site in a patient or animal from where the chemical is absorbed into the blood and delivered to the target tissue. .
Ovarian Neoplasms .
Cancer of the Ovary .
Neoplasms, Ovarian .
Ovary Cancer .
Ovary Neoplasms .
Cancer, Ovarian .
Cancer, Ovary .
Cancers, Ovarian .
Cancers, Ovary .
Neoplasm, Ovarian .
Neoplasm, Ovary .
Neoplasms, Ovary .
Ovarian Cancers .
Ovarian Neoplasm .
Ovary Cancers .
Ovary Neoplasm .
Cancer of Ovary .
Ovarian Cancer .
Ovarian Carcinoma .
Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. .
Photoaffinity Labels .
Labels, Photoaffinity .
Biologically active molecules which are covalently bound to the enzymes or binding proteins normally acting on them. Binding occurs due to activation of the label by ultraviolet light. These labels are used primarily to identify binding sites on proteins. .
Alkylating Agents .
Alkylators .
Agents, Alkylating .
Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. .
Anti-HIV Agents .
Anti-AIDS Drugs .
Anti-HIV Drugs .
Agents, Anti-AIDS .
Agents, Anti-HIV .
Anti AIDS Agents .
Anti AIDS Drugs .
Anti HIV Agents .
Anti HIV Drugs .
Drugs, AIDS .
Drugs, Anti-AIDS .
Drugs, Anti-HIV .
Anti-AIDS Agents .
AIDS Drugs .
Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. .
Anti-Asthmatic Agents .
Anti-Asthmatic Drugs .
Anti-Asthmatics .
Antiasthmatic Agents .
Antiasthmatic Drugs .
Antiasthmatics .
Agents, Anti-Asthmatic .
Agents, Antiasthmatic .
Anti Asthmatic Agents .
Anti Asthmatic Drugs .
Anti Asthmatics .
Drugs, Anti-Asthmatic .
Drugs, Antiasthmatic .
Drugs that are used to treat asthma. .
Administration, Topical .
Administration, Topical Drug .
Topical Administration .
Topical Drug Administration .
Administrations, Topical .
Administrations, Topical Drug .
Drug Administrations, Topical .
Topical Administrations .
Topical Drug Administrations .
Drug Administration, Topical .
The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. .
Sunburn .
Sunburns .
An injury to the skin causing erythema, tenderness, and sometimes blistering and resulting from excessive exposure to the sun. The reaction is produced by the ultraviolet radiation in sunlight. .
Small-Area Analysis .
Analysis, Small-Area .
Small-Area Studies .
Small-Area Variation .
Small-Area Variation Analysis .
Variation Analysis, Small-Area .
Analyses, Small-Area .
Analyses, Small-Area Variation .
Analysis, Small Area .
Analysis, Small-Area Variation .
Small Area Analysis .
Small Area Studies .
Small Area Variation .
Small Area Variation Analysis .
Small-Area Analyses .
Small-Area Study .
Small-Area Variation Analyses .
Small-Area Variations .
Studies, Small-Area .
Study, Small-Area .
Variation Analyses, Small-Area .
Variation Analysis, Small Area .
Variation, Small-Area .
Variations, Small-Area .
A method of analyzing the variation in utilization of health care in small geographic or demographic areas. It often studies, for example, the usage rates for a given service or procedure in several small areas, documenting the variation among the areas. By comparing high- and low-use areas, the analysis attempts to determine whether there is a pattern to such use and to identify variables that are associated with and contribute to the variation. .